Skip to content

Clinical trials

Terminated Cognitive Dysfunction trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Status: Terminated Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20141
20151
20162
20173
20181
20193
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto2
Baycrest1
CHU de Quebec-Universite Laval1
Ciusss de L'Est de l'Île de Montréal1
Eisai Co., Ltd.1
Janssen Research & Development, LLC1
Lakshmi N Yatham1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McGill University1
Nova Scotia Health Authority1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction15
Dementia5
Alzheimer Disease3
Delirium2
Acquired Immunodeficiency Syndrome1
Brain Diseases1
Breast Neoplasms1
Cardiovascular Diseases1
Embolism1
Emergence Delirium1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.